Sheela Foam Ltd

Sheela Foam Ltd

₹ 601 14.84%
04 Feb - close price
About

Sheela Foam Limited is a leading player in India’s mattress and foam products industry and a leader in Polyurethane (PU) Foam. It has a nationwide presence in manufacturing PU Foam with a track record, since 1971. [1]

Key Points

Largest Manufacturer of Polyurethane Foam
The company is India's largest manufacturer of flexible slab stock Polyutherane (PU) foam and mattresses under Sleepwell, Furlenco, and Kurlon [1] with a 30% market share in India’s mattress segment and a 40% market share in Australia. The Kurlon brand holds a 12-13% market share of the modern mattress market.[2] [3] [4]

  • Market Cap 6,524 Cr.
  • Current Price 601
  • High / Low 887 / 498
  • Stock P/E 89.6
  • Book Value 257
  • Dividend Yield 0.00 %
  • ROCE 5.09 %
  • ROE 2.77 %
  • Face Value 5.00

Pros

  • Company has reduced debt.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 8.73% over past five years.
  • Company has a low return on equity of 5.92% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.26%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
515 519 456 423 513 487 504 615 791 691 635 667 842
463 461 395 377 460 437 456 560 720 645 574 604 757
Operating Profit 52 58 61 46 53 50 48 55 71 46 60 63 84
OPM % 10% 11% 13% 11% 10% 10% 9% 9% 9% 7% 9% 9% 10%
24 18 11 22 22 59 37 30 9 20 8 -0 8
Interest 1 2 2 3 18 20 22 22 23 28 23 22 11
Depreciation 8 12 11 13 15 20 19 35 23 24 30 33 31
Profit before tax 67 62 59 52 42 69 44 27 34 13 16 8 50
Tax % 21% 32% 27% 26% 27% 18% 27% 23% 27% 7% 33% 29% 23%
53 42 43 38 31 56 32 21 25 12 11 6 39
EPS in Rs 5.40 4.28 4.38 3.52 2.84 5.18 2.95 1.94 2.29 1.12 0.98 0.52 3.56
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
953 1,077 1,265 1,376 1,580 1,738 1,703 1,694 2,008 2,039 1,880 2,588 2,834
897 1,013 1,124 1,213 1,387 1,555 1,478 1,457 1,774 1,830 1,669 2,352 2,581
Operating Profit 56 64 141 162 193 184 224 237 234 208 210 236 253
OPM % 6% 6% 11% 12% 12% 11% 13% 14% 12% 10% 11% 9% 9%
8 13 21 26 23 30 32 47 70 75 114 95 36
Interest 12 10 7 7 6 7 8 9 7 8 44 94 84
Depreciation 20 22 23 24 28 31 33 33 32 41 58 89 118
Profit before tax 32 46 132 157 182 176 215 243 265 234 222 147 87
Tax % 21% 24% 32% 29% 31% 30% 23% 26% 25% 27% 24% 24%
25 34 90 111 126 124 166 181 197 171 168 112 67
EPS in Rs 7.70 10.60 27.74 11.39 12.90 12.67 16.96 18.56 20.22 17.54 15.48 10.31 6.18
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 9%
5 Years: 9%
3 Years: 9%
TTM: 18%
Compounded Profit Growth
10 Years: 8%
5 Years: -14%
3 Years: -26%
TTM: -29%
Stock Price CAGR
10 Years: %
5 Years: -10%
3 Years: -21%
1 Year: -31%
Return on Equity
10 Years: 13%
5 Years: 9%
3 Years: 6%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 16 16 16 24 24 24 24 24 24 49 54 54 55
Reserves 170 204 294 397 522 645 806 989 1,185 1,313 2,620 2,739 2,742
91 72 46 4 1 0 3 2 19 149 1,000 949 743
193 248 288 350 341 353 337 406 379 406 521 647 681
Total Liabilities 471 540 645 775 888 1,023 1,170 1,421 1,608 1,917 4,196 4,390 4,221
165 190 201 233 254 269 279 278 257 311 504 561 2,239
CWIP 17 8 2 3 4 1 17 1 1 103 80 39 47
Investments 23 30 53 73 195 416 443 623 839 960 3,068 3,112 862
266 311 390 466 436 337 431 519 511 543 543 677 1,073
Total Assets 471 540 645 775 888 1,023 1,170 1,421 1,608 1,917 4,196 4,390 4,221

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
121 110 171 102 114 120 130 178 196 147 246 228
-26 -41 -41 4 -71 -240 -103 -163 -210 -186 -2,160 -53
-54 -31 -32 -50 -9 -8 -9 -9 -6 38 1,915 -165
Net Cash Flow 40 39 97 56 34 -129 18 6 -21 -2 -0 10

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 31 27 21 26 23 22 27 35 25 25 37 34
Inventory Days 51 48 41 52 53 57 73 93 55 63 51 45
Days Payable 52 57 49 63 46 43 50 95 53 57 55 51
Cash Conversion Cycle 30 17 13 15 30 35 50 33 27 30 33 27
Working Capital Days 12 -23 -32 -10 4 9 20 19 13 1 -49 -82
ROCE % 16% 20% 42% 42% 39% 29% 29% 25% 23% 16% 8% 5%

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
72.95% 72.95% 65.48% 65.48% 65.48% 65.48% 65.48% 65.69% 65.69% 65.69% 65.69% 65.69%
3.26% 3.21% 6.04% 6.12% 6.32% 6.40% 6.60% 6.56% 6.23% 4.62% 4.07% 4.18%
22.28% 21.95% 25.08% 24.99% 24.52% 23.40% 22.30% 21.03% 21.17% 21.12% 21.11% 20.39%
1.50% 1.89% 3.40% 3.40% 3.68% 4.72% 5.62% 6.71% 6.91% 8.55% 9.14% 9.75%
No. of Shareholders 27,23230,57444,13739,44439,10351,04755,95460,35460,08965,04670,54472,359

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls